Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-27

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Dexmethylphenidate hydrochloride from Sun Pharmaceutical Industries, Inc. under the ANDA framework. It concerns appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)